A Heartfelt Thank You to Our ReSPECT-GBM & ReSPECT-LM Clinical Trial Participants
To every patient who has participated in the ReSPECT-GBM and ReSPECT-LM clinical trials: THANK YOU! 💙 Your courage and commitment are helping advance critical research for recurrent glioblastoma (GBM) and leptomeningeal metastases (LM)—two of the most challenging conditions in oncology.
Advancing Cancer Research Together
🔹 46 GBM patients and 29 LM patients have already contributed to the ReSPECT trials, bringing us closer to innovative treatments.
🔹 Your participation is driving progress in targeted radiation therapy and precision oncology.
Learn More About Our Clinical Trials:
📌 ReSPECT-GBM Trial – Exploring innovative treatments for recurrent glioblastoma.
🔗 Visit the ReSPECT-GBM Trial
📌 ReSPECT-LM Trial – Advancing research for leptomeningeal metastases.
🔗 Visit the ReSPECT-LM Trial
Stay Connected
Follow us @PlusTherapeutics on all social media platforms for:
✅ Research updates on cutting-edge cancer treatments
✅ Patient stories from those on the frontlines of clinical trials
✅ The latest developments in oncology and precision medicine
#ClinicalTrials #CancerResearch #GBM #Glioblastoma #LeptomeningealMetastases #LMD #Oncology #BrainCancer #PatientCare
Recent Comments